ClinicalTrials.Veeva

Menu

The Role of POLE Mutation in High Risk Endometrial Cancer.

F

Far Eastern Memorial Hospital

Status

Enrolling

Conditions

Endometrial Neoplasms

Study type

Observational

Funder types

Other

Identifiers

NCT07114653
113298-E

Details and patient eligibility

About

The actual role of POLE mutations in high-risk endometrial cancer is undetermined. The main question it aims to answer is:

What is the prevalence of POLE mutations in high-risk endometrial cancer case? What is the impact of POLE mutations in real world high-risk endometrial cancer case?

Full description

All high-risk recurrent endometrial cancer cases who were treated in a tertiary referral center will be analyzed and subjected to POLE mutation analysis. In addition, survival analysis will be used to analyze the role of POLE mutations in women with high-risk endometrial cancer. We can answers the following.

  1. What is the prevalence of POLE mutations in women with high-risk endometrial cancer?
  2. What is the role of POLE mutations in real world high-risk endometrial cancer?

Enrollment

150 estimated patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • women with high-risk for recurrent endometrial cancer

Exclusion criteria

  • Nil

Trial design

150 participants in 1 patient group

endometrial cancer
Description:
high-risk for reurrence of endometrial cancer.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems